Edwards Lifesciences (EW) Income from Non-Controlling Interests (2023 - 2025)
Edwards Lifesciences (EW) recorded quarterly Income from Non-Controlling Interests of $0.0 in Q4 2025, up 100.0% quarter-over-quarter from -$800000.0 in Q3 2025, and up 100.0% on a YoY basis from $0.0 in Q4 2024.
Edwards Lifesciences (EW) Income from Non-Controlling Interests (2023 - 2025) Analysis & Trends
Edwards Lifesciences' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at $0.0 for Q4 2025.
- In Q4 2025, Income from Non-Controlling Interests rose 100.0% year-over-year to $0.0; the TTM figure through Mar 2026 stood at -$2.5 million (up 55.36% YoY), while the FY2025 annual figure was -$4.1 million, up 16.33% from the prior year.
- Income from Non-Controlling Interests was $0.0 for Q4 2025 at Edwards Lifesciences, up from -$800000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $0.0 in Q4 2025 to a low of -$1.7 million in Q2 2025.
- Historically, Income from Non-Controlling Interests has averaged -$1.1 million across 3 years, with a median of -$1.3 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests plunged 550.0% in 2024, then jumped 100.0% in 2025.
- A 3-year view of Income from Non-Controlling Interests shows it stood at -$200000.0 in 2023, then slumped by 550.0% to -$1.3 million in 2024, then surged by 100.0% to $0.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at $0.0 (Q4 2025), -$800000.0 (Q3 2025), and -$1.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -1.70 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | -1.30 Mn |
| Sep 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -1.30 Mn |
| Mar 31, 2024 | -900,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | -1.20 Mn |
| Jun 30, 2023 | -1.60 Mn |